Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
147.06 USD | +2.40% |
|
-2.56% | -25.16% |
04-21 | Jefferies Adjusts Price Target on IQVIA Holdings to $165 From $205, Maintains Hold Rating | MT |
04-17 | Alembic Pharmaceuticals Gets US FDA Final Nod for Carbamazepine Tablets | MT |
Capitalization | 25.93B 22.81B 21.4B 19.52B 35.96B 2,213B 40.62B 250B 97.53B 992B 97.26B 95.24B 3,689B | P/E ratio 2025 * |
19.2x | P/E ratio 2026 * | 16.2x |
---|---|---|---|---|---|
Enterprise value | 37.89B 33.33B 31.27B 28.52B 52.55B 3,234B 59.35B 365B 143B 1,450B 142B 139B 5,390B | EV / Sales 2025 * |
2.39x | EV / Sales 2026 * | 2.2x |
Free-Float |
67.55% | Yield 2025 * |
-
| Yield 2026 * | - |
Last Transcript: Iqvia Holdings Inc.
1 day | +2.40% | ||
1 week | -2.56% | ||
Current month | -16.59% | ||
1 month | -20.89% | ||
3 months | -28.50% | ||
6 months | -36.39% | ||
Current year | -25.16% |
1 week | 137.49 | ![]() | 154.17 |
1 month | 135.97 | ![]() | 188.38 |
Current year | 135.97 | ![]() | 220 |
1 year | 135.97 | ![]() | 252.88 |
3 years | 135.97 | ![]() | 261.73 |
5 years | 122.22 | ![]() | 285.61 |
10 years | 55.01 | ![]() | 285.61 |
Manager | Title | Age | Since |
---|---|---|---|
Ari Bousbib
CEO | Chief Executive Officer | 64 | 02/10/2016 |
Ronald Bruehlman
DFI | Director of Finance/CFO | 64 | 31/07/2020 |
Jeffrey Spaeder
CTO | Chief Tech/Sci/R&D Officer | - | - |
Director | Title | Age | Since |
---|---|---|---|
John Leonard
BRD | Director/Board Member | 67 | 04/02/2015 |
John Connaughton
BRD | Director/Board Member | 59 | 31/12/2007 |
Ari Bousbib
CHM | Chairman | 64 | 02/10/2016 |
Name | Weight | AuM | 1st Jan change | |
---|---|---|---|---|
2.92% | 1 M€ | 0.00% | - |
Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
---|---|---|---|---|---|---|
+2.40% | -2.56% | -36.43% | -37.73% | 25.93B | ||
+2.33% | +5.68% | +10.89% | -10.68% | 48.1B | ||
0.00% | -2.30% | -4.41% | +7.76% | 23.99B | ||
+4.63% | -2.47% | -51.96% | -41.56% | 11.56B | ||
+12.02% | +11.14% | -8.29% | -38.44% | 11.45B | ||
+3.11% | -0.97% | -74.59% | -81.63% | 10.26B | ||
-0.62% | +1.70% | +11.29% | +49.12% | 9.51B | ||
-0.05% | 0.00% | -0.18% | -13.69% | 9.15B | ||
+2.93% | -4.83% | -22.78% | +89.47% | 8.35B | ||
+2.20% | -4.52% | -20.13% | -51.31% | 7.93B | ||
Average | +2.89% | +1.63% | -19.66% | -12.87% | 16.62B | |
Weighted average by Cap. | +2.60% | +1.72% | -13.43% | -14.33% |
2025 * | 2026 * | |
---|---|---|
Net sales | 15.87B 13.97B 13.1B 11.95B 22.02B 1,355B 24.87B 153B 59.71B 608B 59.55B 58.31B 2,259B | 16.8B 14.78B 13.87B 12.65B 23.31B 1,434B 26.32B 162B 63.21B 643B 63.03B 61.72B 2,391B |
Net income | 1.43B 1.25B 1.18B 1.07B 1.98B 122B 2.23B 13.73B 5.36B 54.57B 5.35B 5.24B 203B | 1.64B 1.44B 1.35B 1.23B 2.27B 140B 2.57B 15.77B 6.16B 62.69B 6.14B 6.02B 233B |
Net Debt | 11.96B 10.52B 9.87B 9B 16.58B 1,021B 18.73B 115B 44.98B 458B 44.85B 43.92B 1,701B | 11.08B 9.75B 9.14B 8.34B 15.37B 946B 17.36B 107B 41.68B 424B 41.56B 40.7B 1,576B |
Date | Price | Change | Volume |
---|---|---|---|
23/04/25 | 147.06 $ | +2.40% | 2,294,958 |
22/04/25 | 143.61 $ | +1.69% | 1,734,183 |
21/04/25 | 141.22 $ | -1.87% | 1,967,486 |
17/04/25 | 143.91 $ | -3.05% | 3,302,598 |
16/04/25 | 148.44 $ | -0.48% | 1,322,238 |
Delayed Quote Nyse, April 23, 2025 at 09:00 pm
More quotes
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- IQV Stock

MarketScreener is also available in this country: United States.
Switch edition